Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Nat Rev Neurol. 2017 Feb 10;13(3):171–191. doi: 10.1038/nrneurol.2017.13

Table 1.

Human Studies of Neuroinflammation after TBI: Triggers / Brakes

Inflammatory mediator Tissue / Fluid Time Course Association with clinical outcome(s) Other Ref
Triggers / Brakes
Adenosine CSF
ECF
Increased within hours of injury

Rapidly decline over 12–24h
Pediatric: No association with outcome after severe TBI

Adult: Higher level in patients that died after severe TBI
A1AR gene variants associated with post-traumatic epilepsy

Increased CSF adenosine associated with jugular vein desaturation
222224
Complement CSF Peak day 1 post-injury, decline day 2–7 Adult: Increased MAC level associated with BBB dysfunction in severe TBI C3 and Factor B increased relative to controls 58,225
Tissue Increased in tissue resected 2–82h post-injury Unknown C3-mRNA also detected in penumbra, suggesting a contribution of local synthesis 57
Glutamate CSF
ECF
Multiple courses described

Most common peak day 1, decline day 2–3
Pediatric: Higher level associated with poor 6mo-GOS in severe TBI

Adult: Increase in ECF glutamate associated with poor outcomes
Increased glutamate associated with age < 4 and child abuse

Hourly levels not affected by transient hemodynamic or ICP change
41,226228
HMGB1 CSF No change over time Pediatric: Higher level associated with unfavorable 6 month GOS in severe TBI

Adults: Increased level associated with high ICP
Not associated with age or mechanism of injury 27,28
Tissue Translocated to cytoplasm of cells in contused area at 30min – 1d

Localized to cytoplasm of phagocytic microglia at 2–20d
Unknown HMGB1 receptor, RAGE, expression also increased in contused area in phagocytic microglia 229
NLRP1 CSF Unknown Adult: Higher level in patients with unfavorable 5 month GOS in moderate to severe TBI Adaptor protein ASC also increased in CSF of TBI patients 230
Caspase-1 CSF Unknown Adult: Higher level in patients with unfavorable 5mo-GOS in moderate to severe TBI Identified by p20 subunit suggests activated form of enzyme 230
Tissue Pro-caspase-1 is cleaved to active form on day 1 Unknown 231
mtDNA CSF Peak day 1, declined on day 3, though still above control Pediatric: Higher levels associated with unfavorable 6mo- GOS in severe TBI Positively correlated with HMGB1 level 52

Abbreviations: TBI – traumatic brain injury; CSF – Cerebrospinal fluid; ECF – Extracellular fluid; A1AR – adenosine receptor A1; MAC – membrane attack complex; ICP – intracranial pressure; HMGB1 – high mobility group box 1; RAGE – receptor for advanced glycation endproducts; NLRP1 – NACHT, LRR and PYD domains-containing protein 1; GOS – Glasgow Outcome Scale; mtDNA – mitochondria DNA; BBB – blood brain barrier; GCS – Glasgow Coma Scale